GARUFI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 476
EU - Europa 323
AS - Asia 107
OC - Oceania 1
Totale 907
Nazione #
US - Stati Uniti d'America 474
IE - Irlanda 77
IT - Italia 73
SE - Svezia 52
CN - Cina 47
UA - Ucraina 35
DE - Germania 30
GB - Regno Unito 29
TR - Turchia 24
VN - Vietnam 17
FR - Francia 7
IN - India 7
BE - Belgio 6
FI - Finlandia 6
HK - Hong Kong 4
JP - Giappone 3
RO - Romania 3
SG - Singapore 3
CA - Canada 2
AT - Austria 1
AU - Australia 1
IL - Israele 1
KR - Corea 1
MD - Moldavia 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
Totale 907
Città #
Chandler 121
Dublin 76
Jacksonville 66
Princeton 38
Ann Arbor 29
Ashburn 28
Southend 24
Wilmington 21
Altamura 18
Dong Ket 17
Nanjing 17
Falls Church 13
Chieti 12
Izmir 12
Dearborn 10
Nanchang 10
Cambridge 9
Washington 7
Brussels 6
Rome 6
Grafing 5
Houston 5
Beijing 4
Boardman 4
Hong Kong 4
New York 4
Macerata 3
Buffalo 2
Changchun 2
Changsha 2
Edinburgh 2
Guangzhou 2
Hebei 2
Kunming 2
L'aquila 2
Menlo Park 2
Norwalk 2
Seattle 2
Tianjin 2
Adelaide 1
Andover 1
Atlanta 1
Bologna 1
Bucharest 1
Burnaby 1
Chicago 1
Chisinau 1
Florence 1
Fuzhou 1
Guidonia 1
Hangzhou 1
Helsinki 1
Lanzhou 1
Las Vegas 1
Los Angeles 1
Minervino Murge 1
Minneapolis 1
Parma 1
Pescara 1
Salerno 1
San Mateo 1
Shenyang 1
Singapore 1
Sittard 1
Tel Aviv 1
Tokyo 1
Toronto 1
Tottori 1
Vienna 1
Warsaw 1
Woodbridge 1
Totale 625
Nome #
Zn(II)-curc targets p53 in thyroid cancer cells 96
Hyperglycemia triggers HIPK2 protein degradation 78
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies 77
The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells 72
Reactivation of mutant p53 by capsaicin, the major constituent of peppers 72
HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like 68
ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose 61
P53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions 58
Clearing mutant p53 with natural compounds: implication for anticancer therapeutical approaches 58
Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences 54
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response 45
Interplay between endoplasmic reticulum (ER) stress and autophagy induces mutant p53H273 degradation 45
PBA preferentially impairs cell survival of glioblastomas carrying mutp53 by reducing its expression level, stabilizing wtp53, downregulating the mevalonate kinase and dysregulating UPR 45
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 43
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status 43
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study 30
P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex 23
Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity 21
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells 14
HIPK2 as a Novel Regulator of Fibrosis 10
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases 6
New Copper-Based Metallodrugs with Anti-Invasive Capacity 4
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study 2
Totale 1.025
Categoria #
all - tutte 4.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 0 13
2019/2020193 58 10 2 12 13 9 22 13 13 19 12 10
2020/2021100 14 1 14 4 5 18 6 1 11 4 0 22
2021/2022115 1 2 1 3 7 14 6 3 16 16 13 33
2022/2023326 23 61 21 41 20 57 15 22 41 0 19 6
2023/2024130 10 5 14 5 10 35 29 15 2 5 0 0
Totale 1.025